IT1158040B - 2-/4-/4,4-dialchil-2,6-piperidinadion-1-il)butil/1-piperazinil/piridine ad attivita' antipsicotica relativo procedimento di preparazione e preparati farmaceutici che le contengono - Google Patents

2-/4-/4,4-dialchil-2,6-piperidinadion-1-il)butil/1-piperazinil/piridine ad attivita' antipsicotica relativo procedimento di preparazione e preparati farmaceutici che le contengono

Info

Publication number
IT1158040B
IT1158040B IT49720/82A IT4972082A IT1158040B IT 1158040 B IT1158040 B IT 1158040B IT 49720/82 A IT49720/82 A IT 49720/82A IT 4972082 A IT4972082 A IT 4972082A IT 1158040 B IT1158040 B IT 1158040B
Authority
IT
Italy
Prior art keywords
piperidinadion
piperazinyl
dialkyl
pyridine
butyl
Prior art date
Application number
IT49720/82A
Other languages
English (en)
Other versions
IT8249720A0 (it
Inventor
Davis L Temple
Joseph P Yevich
Walter G Lobeck
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IT8249720A0 publication Critical patent/IT8249720A0/it
Application granted granted Critical
Publication of IT1158040B publication Critical patent/IT1158040B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
IT49720/82A 1981-12-28 1982-12-22 2-/4-/4,4-dialchil-2,6-piperidinadion-1-il)butil/1-piperazinil/piridine ad attivita' antipsicotica relativo procedimento di preparazione e preparati farmaceutici che le contengono IT1158040B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/334,689 US4361565A (en) 1981-12-28 1981-12-28 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines

Publications (2)

Publication Number Publication Date
IT8249720A0 IT8249720A0 (it) 1982-12-22
IT1158040B true IT1158040B (it) 1987-02-18

Family

ID=23308356

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49720/82A IT1158040B (it) 1981-12-28 1982-12-22 2-/4-/4,4-dialchil-2,6-piperidinadion-1-il)butil/1-piperazinil/piridine ad attivita' antipsicotica relativo procedimento di preparazione e preparati farmaceutici che le contengono

Country Status (27)

Country Link
US (1) US4361565A (it)
JP (1) JPS58118583A (it)
KR (1) KR880002011B1 (it)
AT (1) AT380880B (it)
AU (1) AU560667B2 (it)
BE (1) BE895505A (it)
CA (1) CA1237722A (it)
CH (1) CH653682A5 (it)
CY (1) CY1378A (it)
DE (1) DE3248138A1 (it)
DK (1) DK162284C (it)
ES (1) ES518511A0 (it)
FI (1) FI70892C (it)
FR (1) FR2518994B1 (it)
GB (1) GB2114121B (it)
GR (1) GR77101B (it)
HK (1) HK5188A (it)
HU (1) HU190827B (it)
IE (1) IE54620B1 (it)
IT (1) IT1158040B (it)
KE (1) KE3714A (it)
LU (1) LU84562A1 (it)
NL (1) NL8204974A (it)
PT (1) PT76037B (it)
SE (1) SE449748B (it)
SG (1) SG29687G (it)
ZA (1) ZA828546B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT387221B (de) * 1980-09-08 1988-12-27 Bristol Myers Co Verfahren zur herstellung des neuen
AT387773B (de) * 1983-09-12 1989-03-10 Bristol Myers Co Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
CA1278792C (en) * 1985-05-06 1991-01-08 Joseph P. Yevich Antipsychotic fused-ring pyridinylpiperazine derivatives
US4757073A (en) * 1986-09-30 1988-07-12 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use
US4855430A (en) * 1987-11-12 1989-08-08 American Home Products Corporation Polycyclicamine with psychotropic activity
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US5116970A (en) * 1988-02-18 1992-05-26 New James S Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
US5098904A (en) * 1990-06-27 1992-03-24 Bristol-Myers Squibb Company Cerebral function enhancing pyrimidinyl derivatives
ES2084763T3 (es) * 1990-10-23 1996-05-16 Akzo Nobel Nv 4-(4- o 6-(2-trifluormetil piridinil))1-piperazinilalquilo lactamas sustituidas.
WO1992011011A1 (en) * 1990-12-24 1992-07-09 Merrell Dow Pharmaceuticals Inc. Use of certain glutarimide derivatives in the treatment of depression and mania
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
JP4533534B2 (ja) 1998-06-19 2010-09-01 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド グリコーゲンシンターゼキナーゼ3のインヒビター
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
HUE031039T2 (en) * 2007-03-29 2017-06-28 Joint-Stock Company Obninsk Chemical Pharmaceutical Company An antihistamine and an anti-allergenic agent and a method for its preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
FI791926A (fi) * 1978-06-20 1979-12-21 Synthelabo Fenylpiperazinderivat
US4305944A (en) * 1980-09-08 1981-12-15 Mead Johnson & Company N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones

Also Published As

Publication number Publication date
AU560667B2 (en) 1987-04-16
US4361565A (en) 1982-11-30
DK573282A (da) 1983-06-29
IE54620B1 (en) 1989-12-20
FR2518994B1 (fr) 1986-09-05
DK162284C (da) 1992-03-16
FI824443L (fi) 1983-06-29
FI70892B (fi) 1986-07-18
SE8207426L (sv) 1983-06-29
HU190827B (en) 1986-11-28
IT8249720A0 (it) 1982-12-22
BE895505A (fr) 1983-06-28
CA1237722A (en) 1988-06-07
FI70892C (fi) 1986-10-27
LU84562A1 (fr) 1983-09-08
FI824443A0 (fi) 1982-12-23
ES8402832A1 (es) 1984-03-01
DE3248138C2 (it) 1992-12-10
CY1378A (en) 1987-08-07
GB2114121A (en) 1983-08-17
ES518511A0 (es) 1984-03-01
JPH0567637B2 (it) 1993-09-27
DE3248138A1 (de) 1983-07-07
PT76037B (en) 1985-12-16
HK5188A (en) 1988-01-29
AU9108482A (en) 1983-07-07
GR77101B (it) 1984-09-06
DK162284B (da) 1991-10-07
NL8204974A (nl) 1983-07-18
AT380880B (de) 1986-07-25
ATA467682A (de) 1985-12-15
ZA828546B (en) 1983-09-28
SG29687G (en) 1987-07-17
SE8207426D0 (sv) 1982-12-27
SE449748B (sv) 1987-05-18
GB2114121B (en) 1985-11-27
KE3714A (en) 1987-04-16
CH653682A5 (de) 1986-01-15
PT76037A (en) 1983-01-01
JPS58118583A (ja) 1983-07-14
IE823068L (en) 1983-06-28
KR880002011B1 (ko) 1988-10-12
KR840002826A (ko) 1984-07-21
FR2518994A1 (fr) 1983-07-01

Similar Documents

Publication Publication Date Title
IT1158040B (it) 2-/4-/4,4-dialchil-2,6-piperidinadion-1-il)butil/1-piperazinil/piridine ad attivita' antipsicotica relativo procedimento di preparazione e preparati farmaceutici che le contengono
IT1158039B (it) 2-/4-/(4,4-dialchil-2,6-piperidindion-1-il)-butil/1-piperazinil/pirimidine ad attivita' ansiolitica selettiva, procedimento per la loro preparazione e preparati farmaceutici che le contengono
DK164868C (da) Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
IT8249709A0 (it) Derivati piperazinici del benzoisotiazolo e del benzoisoossazolo aventi attivita' antipsicotica selettiva relativo procedimento di produzione e preparati farmaceutica cheli contengono
DK166149C (da) Antipsykotiske 1-fluorphenylbutyl-4-(2-pyrimidinyl)-piperazinderivater, farmaceutiske praeparater indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
DK163923C (da) 2-phenyl-3-aminomethyl-imidazooe1,2-aaapyridinderivater og farmaceutisk praeparat indeholdende saadanne forbindelser
DK259186D0 (da) Nasale farmaceutiske praeparater
DK165635C (da) 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxy-derivater, farmaceutisk praeparat omfattende saadanne forbindelser, samt fremgangsmaade til fremstilling af forbindelserne
NL8601838A (nl) Distamycinederivaten, werkwijze voor de bereiding ervan, alsmede farmaceutische preparaten, die deze derivaten bevatten.
DK164594C (da) 1,4-dihydro-pyridin-3,5-yl-dicarboxylsyrederivater, farmaceutiske praeparater indeholdende disse derivater samt fremgangsmaade til fremstilling deraf
DK408186D0 (da) Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne
DK161383C (da) Quinolincarboxylsyre-derivat, fremgangsmaade til fremstilling heraf samt antibakterielle farmaceutiske praeparater indeholdende dette
DK163057C (da) Isoindsolinyl-alkyl-piperaziner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK165006C (da) Kromoglycinsyrederivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat
NO862439D0 (no) Farmasoeytiske preparater.
DK342187A (da) 4-pyridin-derivater, fremgangsmaade til fremstilling af saadanne derivater samt farmaceutiske praeparater indeholdende disse
DK354485A (da) 3-substituerede l-aminoalkyl-lh-indol-forbindelser, fremgangsmaader til fremstilling deraf og mellemprodukter til anvendelse derved samt farmaceutiske praeparater
DK111686A (da) Gelholdige farmaceutiske praeparater
DK165745C (da) Pyridinylpiperazinderivater med kondenseret ringsystem, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende forbindelserne.
DK527487A (da) Farmaceutiske praeparater med forlaenget afgivelse
DK262186D0 (da) Quinolinderivater, farmaceutisk praeparat indeholdende saadanne forbindelser og fremgangsmaade til fremstilling deraf
DK409986D0 (da) 3-desmethyl-mevalonsyrederivater, fremgangsmaade til fremstillingderaf, pharmaceutiske praeparater paa basis af disse forbindelser, anvendelse deraf samt mellemprodukter
DK370085A (da) Antianafylaktisk virksomme farmaceutiske praeparater
DK449989A (da) Quinolinderivater, deres fremstilling og laegemidler indeholdende disse derivater
DK645988A (da) Biphenylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeprater indeholdende samme